Share this page!

NewsBytes Profile picture
Twitter logo
18 Dec, 4 tweets, 3 min read
#PremierLeague clubs will be allowed to make up to two concussion substitutions per match from January 2021
newsbytesapp.com/news/sports/co…
The additional concussion substitutions may be made regardless of the number of substitutions a team has made already #PremierLeague
newsbytesapp.com/news/sports/co… Image
#PremierLeague clubs have voted down the reinstatement of five regular replacements
newsbytesapp.com/news/sports/co…
Replacement bench expanded from seven to nine players #PremierLeague
newsbytesapp.com/news/sports/co… Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with NewsBytes

NewsBytes Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NewsBytesApp

NewsBytes Profile picture
19 Dec
Centre releases FAQs on India's COVID-19 vaccination drive #CoronavirusVaccine
newsbytesapp.com/news/india/cen…
The Union Health Ministry issued 21 FAQs for the public and six FAQs for the healthcare providers and frontline workers #CoronavirusVaccine
newsbytesapp.com/news/india/cen…
COVID-19-positive patients should defer vaccination for 14 days #CoronavirusVaccine
newsbytesapp.com/news/india/cen… Image
Read 6 tweets
NewsBytes Profile picture
19 Dec
India bowled out for their lowest Test score #AusvsInd
newsbytesapp.com/news/sports/au…
The lowest score for India at the fall of the sixth wicket (19/6)

The previous worst-record was 25/6 vs South Africa, Durban, 1996 #AusvsInd

newsbytesapp.com/news/sports/au…
#Kohli didn't slam a single international ton in 2020 #AusvsInd
newsbytesapp.com/news/sports/au… Image
Read 4 tweets
NewsBytes Profile picture
29 Aug
A team of surgeons at a Chennai hospital performed a bilateral lung transplant (double-lung transplant) on a patient of COVID-19

This was the first lung transplant conducted on a COVID-19 patient in Asia

newsbytesapp.com/timeline/india…
The patient who received the transplant is a 48-year-old man from Delhi

He tested positive for the coronavirus infection on June 8 and had sustained severe lung damage due to COVID-related fibrosis
A statement from the hospital said, "His condition continued to worsen in spite of ventilator support, he was airlifted to MGM Healthcare in Chennai from Ghaziabad on July 20"
Read 6 tweets
NewsBytes Profile picture
27 Aug
Coronavirus vaccine tracker: When will the one be ready?
newsbytesapp.com/timeline/scien…
Oxford-AstraZeneca vaccine -

The vaccine developed by Oxford University in collaboration with the pharmaceutical firm AstraZeneca is undergoing phase 2 trials in India and phase 3 trials in other parts of the world
The vaccine candidate—called AZD1222 (formerly ChAdOx1 nCoV-19)—is being manufactured by the Serum Institute of India in India

It is expected to be ready by December 2020 with an estimated price of $4 (Rs. 295)
Read 9 tweets
NewsBytes Profile picture
25 Aug
A 33-year-old man in Hong Kong has contracted COVID-19 twice this year in what is said to be the first documented case of reinfection
newsbytesapp.com/timeline/world…
The man had been infected earlier this year in March and got reinfected in August, the study said

According to the pre-print study, the man's second case of COVID-19 occurred 142 days after the first bout
The 33-year-old had first tested positive for the virus on March 26

He experienced a cough, sore throat, fever, and headache

During the second infection, the man tested positive during entry screening at the Hong Kong airport on August 15

He remained asymptomatic this time
Read 9 tweets
NewsBytes Profile picture
22 Aug
Hyderabad-based Bharat Biotech has been allowed to conduct a trial to test administer its COVID-19 vaccine candidate through the skin (intradermal vaccine delivery)
newsbytesapp.com/timeline/india…
The method is said to be more effective as it requires a lower dose of vaccine compared to intramuscular routes, thus lowering the per injection cost

The vaccine candidate, called COVAXIN, is already undergoing trials for intramuscular vaccine delivery
Bharat Biotech, which developing COVAXIN in collaboration with the Indian Council of Medical Research (ICMR), has now become the first Indian company to be experimenting a potential vaccine in both intradermal and intramuscular methods
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @NewsBytesApp has new unrolls!

Check out other threads from @NewsBytesApp!

Read all threads by @NewsBytesApp